Related Experiment Videos

Reversible changes in norepinephrine extraction by the lungs in children with pulmonary hypertension

Pediatric Pharmacology (New York, N.Y.)
|January 1, 1982
PubMed

Insights

Pulmonary artery hypertension in children with congenital heart disease impairs the lung's ability to extract norepinephrine. This impaired extraction is reversible after surgical correction of the heart defect.

Area of Science:

  • Cardiovascular Physiology
  • Pulmonary Medicine
  • Pediatric Cardiology

Background:

  • The lung's pulmonary microcirculation metabolizes vasoactive hormones, influencing systemic vasomotor tone.
  • Congenital heart disease (CHD) can lead to pulmonary artery hypertension (PAH), potentially affecting lung metabolic functions.

Purpose of the Study:

  • To investigate the impact of PAH secondary to CHD on the lung's extraction of vasoactive hormones, specifically norepinephrine (NE) and epinephrine (EPI).
  • To assess the reversibility of these effects after surgical intervention for CHD.

Main Methods:

  • Studied 11 pediatric patients with CHD, divided into normal pulmonary artery pressure (PAP) and PAH groups.
  • Collected pre- and post-operative blood samples from the pulmonary artery and aorta.
  • Measured NE and EPI levels using radioenzymatic assay.

Main Results:

  • Preoperatively, PAH patients exhibited higher circulating NE levels and lower NE extraction compared to controls.
  • EPI extraction was negligible in all groups.
  • Postoperatively, NE extraction improved in PAH patients after PAP reduction, reaching levels comparable to controls.

Conclusions:

  • The pediatric lung selectively extracts catecholamines.
  • Elevated PAP in CHD is associated with reduced NE extraction and increased circulating NE.
  • Surgical repair of CHD improves NE extraction, indicating the reversibility of PAH-induced metabolic dysfunction.

Related Concept Videos